Kilitch Drugs (India) Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 51.16 | 36.63 | 40.03 |
| Operating Expense | 39.75 | 30.20 | 33.92 |
| Net Profit | 8.85 | 4.05 | 3.64 |
| Net Profit Margin | 17.30 | 11.06 | 9.09 |
| Earning Per Share | 5.50 | 2.52 | 2.26 |
| EBIDTA | 11.83 | 6.16 | 5.81 |
| Effective Tax Rate | 18.95 | 19.75 | 21.60 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 51.16 |
| Operating Expense | 39.75 |
| Net Profit | 8.85 |
| Net Profit Margin | 17.30 |
| Earning Per Share | 5.50 |
| EBIDTA | 11.83 |
| Effective Tax Rate | 18.95 |
Invest in Kilitch Drugs (India) Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 131.60 | 117.78 | 105.16 |
| Operating Expenses Annual | 111.28 | 100.61 | 94.16 |
| Operating Profit Annual | 26.51 | 21.77 | 15.56 |
| Interest Annual | 1.91 | 0.99 | 0.66 |
| Depreciation | 1.24 | 1.34 | 0.96 |
| Net Profit Annual | 17.57 | 15.72 | 10.53 |
| Tax Annual | 5.78 | 3.73 | 3.40 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 131.60 |
| Operating Expenses Annual | 111.28 |
| Operating Profit Annual | 26.51 |
| Interest Annual | 1.91 |
| Depreciation | 1.24 |
| Net Profit Annual | 17.57 |
| Tax Annual | 5.78 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 17.84 | 2.45 | 5.77 |
| Cash Flow from Operations | -11.19 | 6.10 | 5.21 |
| Cash Flow from Investing | -10.10 | 6.24 | -16.08 |
| Cash Flow from Financing | 11.40 | 3.04 | 7.55 |
| Cash Flow at the End | 7.95 | 17.84 | 2.45 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 17.84 |
| Cash Flow from Operations | -11.19 |
| Cash Flow from Investing | -10.10 |
| Cash Flow from Financing | 11.40 |
| Cash Flow at the End | 7.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 20.23 | 18.63 | 14.92 |
| PBIT Margin (%) | 19.29 | 17.49 | 14.01 |
| PBT Margin (%) | 9.75 | 2.28 | -3.50 |
| Net PROFIT Margin (%) | 13.35 | 13.35 | 10.01 |
| Return On Networth / Equity (%) | 8.39 | 8.41 | 6.18 |
| Return On Networth /Employed (%) | 10.74 | 9.89 | 7.82 |
| Return On Assets (%) | 7.48 | 7.61 | 5.61 |
| Total Debt / Equity (X) | 0.13 | 0.11 | 0.10 |
| Asset Turnover Ratio (%) | 0.56 | 0.57 | 0.56 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 20.23 |
| PBIT Margin (%) | 19.29 |
| PBT Margin (%) | 9.75 |
| Net PROFIT Margin (%) | 13.35 |
| Return On Networth / Equity (%) | 8.39 |
| Return On Networth /Employed (%) | 10.74 |
| Return On Assets (%) | 7.48 |
| Total Debt / Equity (X) | 0.13 |
| Asset Turnover Ratio (%) | 0.56 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 15.70 | 15.08 | 14.18 |
| Total Current Assets Annual | 141.49 | 114.77 | 97.72 |
| Non Current Assets Annual | 145.98 | 137.65 | 134.57 |
| Total Shareholders Funds Annual | 222.92 | 195.93 | 178.03 |
| Total Assets Annual | 287.47 | 252.42 | 232.29 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 15.70 |
| Total Current Assets Annual | 141.49 |
| Non Current Assets Annual | 145.98 |
| Total Shareholders Funds Annual | 222.92 |
| Total Assets Annual | 287.47 |
EPS (INR)
Expected
5.36
Reported
5.36
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.45%
